Along with its JV partner, Ainnova Tech, Inc., a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are exploring options to integrate the early detection of dementia into Ainnova's proprietary, AI-powered platform technology, Vision AI. Avant Technologies Inc shares O.AVAI are trading off $0.02 at $0.60.
Stocks in play: Avant Technologies Inc
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here